Does location of an non-spinal osseous metastasis affect your SBRT dosing?
What is your normal dose-fractionation in this scenario?
Do you change your dosing if the lesion is in a weight bearing structure (femoral head/neck, tibia, etc.)?
Are there any other factors that influence your dosing?
2 Answers
Mednet MemberInvited Expert
Radiation Oncology · Memorial Sloan Kettering Cancer Center
Answered on
Just a few thoughts: Location is an important consideration for SBRT dosing because normal tissue tolerances vary by organ/location. Three complications that I worry about are the risk of bone fracture, neuropathy and myositis when treating non spinal osseous mets with SBRT, especially in the settin...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Radiation Oncology · University of Washington School of Medicine
Answered on
Proximity to visceral organs and joints and whether the bone is weight-bearing are factors that I will consider. I favor multisession SBRT for higher risk bone metastases.
Join for free or sign in to see the full answer